• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高甘油三酯血症作为卒中可能的独立危险因素。

Hypertriglyceridemia as a possible independent risk factor for stroke.

作者信息

Lisak Marijana, Demarin Vida, Trkanjec Zlatko, Basić-Kes Vanja

出版信息

Acta Clin Croat. 2013 Dec;52(4):458-63.

PMID:24696996
Abstract

There are no reliable data on the relationship between ischemic stroke and elevated triglyceride levels. Results of previous studies have shown that elevated total cholesterol, high low-density lipoprotein cholesterol (LDL-C) and low high-density lipoprotein cholesterol (HDL-C) are modifiable risk factors for ischemic stroke. Recent evidence suggests that hypertriglyceridemia correlates with an increased risk of cardiovascular disease, particularly if the levels of HDL cholesterol are low and the levels of LDL cholesterol are high. The role of hypertriglyceridemia as an independent risk factor for stroke remains questionable, although correlation between elevated triglycerides and recurrent ischemic stroke has been established. Hypertriglyceridemia is an essential feature of metabolic syndrome, the most important risk factor for atherosclerosis and prothrombotic state, and both correlate with the increased risk of stroke. Lowering triglyceride levels might have a positive effect in stroke risk reduction. Efficacy of gemfibrozil was demonstrated in secondary stroke prevention in patients with coronary heart disease and elevated triglyceride levels. Fibrate derivatives might be utilized in primary stroke prevention, but their efficacy has not yet been established. There is substantial evidence to conclude that hypertriglyceridemia might be an independent risk factor for stroke, but additional studies are mandatory to confirm this presumption.

摘要

关于缺血性中风与甘油三酯水平升高之间的关系,目前尚无可靠数据。先前的研究结果表明,总胆固醇升高、低密度脂蛋白胆固醇(LDL-C)水平高以及高密度脂蛋白胆固醇(HDL-C)水平低是缺血性中风的可改变风险因素。最近的证据表明,高甘油三酯血症与心血管疾病风险增加相关,尤其是在HDL胆固醇水平低且LDL胆固醇水平高的情况下。尽管甘油三酯升高与复发性缺血性中风之间已建立关联,但高甘油三酯血症作为中风独立危险因素的作用仍存在疑问。高甘油三酯血症是代谢综合征的一个重要特征,代谢综合征是动脉粥样硬化和血栓前状态的最重要危险因素,二者均与中风风险增加相关。降低甘油三酯水平可能对降低中风风险有积极作用。吉非贝齐在冠心病和甘油三酯水平升高患者的二级中风预防中显示出疗效。贝特类衍生物可用于一级中风预防,但其疗效尚未得到证实。有大量证据可以得出结论,高甘油三酯血症可能是中风的独立危险因素,但还需要更多研究来证实这一推测。

相似文献

1
Hypertriglyceridemia as a possible independent risk factor for stroke.高甘油三酯血症作为卒中可能的独立危险因素。
Acta Clin Croat. 2013 Dec;52(4):458-63.
2
Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.高甘油三酯血症:临床相关性与治疗选择综述:聚焦于西立伐他汀
Curr Med Res Opin. 2001;17(1):60-73.
3
Low high-density lipoprotein cholesterol as the possible risk factor for stroke.低高密度脂蛋白胆固醇作为中风的潜在危险因素。
Acta Clin Croat. 2010 Dec;49(4):429-39.
4
Triglyceride as a risk factor for coronary artery disease.甘油三酯作为冠状动脉疾病的一个风险因素。
Am J Cardiol. 1998 Nov 5;82(9A):22Q-25Q. doi: 10.1016/s0002-9149(98)00770-x.
5
[Statin therapy for atherogenic hypertriglyceridemia].[他汀类药物治疗致动脉粥样硬化性高甘油三酯血症]
Nihon Rinsho. 2013 Sep;71(9):1655-60.
6
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.吉非贝齐用于高密度脂蛋白胆固醇水平低的男性冠心病二级预防。退伍军人事务部高密度脂蛋白胆固醇干预试验研究组。
N Engl J Med. 1999 Aug 5;341(6):410-8. doi: 10.1056/NEJM199908053410604.
7
High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.高密度脂蛋白胆固醇和甘油三酯作为预防和治疗冠状动脉疾病的治疗靶点。
Am Heart J. 2002 Dec;144(6 Suppl):S33-42. doi: 10.1067/mhj.2002.130301.
8
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.高甘油三酯血症、致动脉粥样硬化性血脂异常与代谢综合征。
Am J Cardiol. 1998 Feb 26;81(4A):18B-25B. doi: 10.1016/s0002-9149(98)00033-2.
9
Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial.吉非贝齐对高密度脂蛋白胆固醇水平低的冠心病患者的成本效益:退伍军人事务部高密度脂蛋白胆固醇干预试验
Arch Intern Med. 2002 Jan 28;162(2):177-82. doi: 10.1001/archinte.162.2.177.
10
Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.在 LDL-胆固醇<70mg/dl 的他汀类药物治疗的冠心病男性中,与低高密度脂蛋白胆固醇和高甘油三酯相关的胆固醇流出和代谢异常。
Am J Cardiol. 2012 Mar 1;109(5):636-41. doi: 10.1016/j.amjcard.2011.10.017. Epub 2011 Dec 9.

引用本文的文献

1
Prevalence of hypertriglyceridemia among Royal Thai Army personnel and its related cardiometabolic risk factors, from 2017 to 2021.2017 年至 2021 年泰国皇家陆军人员高甘油三酯血症的流行情况及其相关的心血管代谢危险因素。
BMC Public Health. 2022 Aug 17;22(1):1569. doi: 10.1186/s12889-022-13992-2.
2
Dyslipidemia in Acute Non-cardioembolic Ischemic Stroke Patients at a Tertiary Care Centre: A Descriptive Cross-sectional Study.三级保健中心急性非心源性缺血性脑卒中患者的血脂异常:一项描述性横断面研究。
JNMA J Nepal Med Assoc. 2022 Mar 11;60(247):241-245. doi: 10.31729/jnma.7321.
3
Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions.
降低胆固醇的植物化学物质:靶向甲羟戊酸途径进行抗癌干预
Front Genet. 2022 Mar 22;13:841639. doi: 10.3389/fgene.2022.841639. eCollection 2022.
4
Prevalence and predictors of stroke among individuals with prediabetes and diabetes in Florida.佛罗里达州糖尿病前期和糖尿病患者中风的患病率及其预测因素。
BMC Public Health. 2022 Feb 6;22(1):243. doi: 10.1186/s12889-022-12666-3.
5
Matrix Metalloproteinase-9 Gene Polymorphism and Its Methylation in Stroke Patients.基质金属蛋白酶-9基因多态性及其甲基化与中风患者的关系
Malays J Med Sci. 2021 Dec;28(6):32-41. doi: 10.21315/mjms2021.28.6.4. Epub 2021 Dec 22.
6
Metabolomic profiling identifies complex lipid species and amino acid analogues associated with response to weight loss interventions.代谢组学分析鉴定出与体重减轻干预反应相关的复杂脂质种类和氨基酸类似物。
PLoS One. 2021 May 27;16(5):e0240764. doi: 10.1371/journal.pone.0240764. eCollection 2021.
7
A Role for Caveolin-3 in the Pathogenesis of Muscular Dystrophies.小窝蛋白-3在肌营养不良发病机制中的作用。
Int J Mol Sci. 2020 Nov 19;21(22):8736. doi: 10.3390/ijms21228736.
8
Cardiovascular Risk Estimated by UKPDS Risk Engine Algorithm in Diabetes.英国前瞻性糖尿病研究(UKPDS)风险引擎算法评估的糖尿病心血管风险
Open Med (Wars). 2018 Dec 31;13:610-617. doi: 10.1515/med-2018-0086. eCollection 2018.
9
HSPA12A is required for adipocyte differentiation and diet-induced obesity through a positive feedback regulation with PPARγ.HSPA12A 通过与 PPARγ 的正反馈调节,对于脂肪细胞分化和饮食诱导的肥胖是必需的。
Cell Death Differ. 2019 Nov;26(11):2253-2267. doi: 10.1038/s41418-019-0300-2. Epub 2019 Feb 11.
10
Risk Factors, Clinical Features and Prognosis for Subtypes of Ischemic Stroke in a Chinese Population.中国人群缺血性脑卒中亚型的危险因素、临床特征和预后。
Curr Med Sci. 2018 Apr;38(2):296-303. doi: 10.1007/s11596-018-1878-1. Epub 2018 Apr 30.